First Time Loading...

ADC Therapeutics SA
NYSE:ADCT

Watchlist Manager
ADC Therapeutics SA Logo
ADC Therapeutics SA
NYSE:ADCT
Watchlist
Price: 4.44 USD -7.11% Market Closed
Updated: Apr 26, 2024

ADC Therapeutics SA
Long-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

ADC Therapeutics SA
Long-Term Debt Peer Comparison

Comparables:
ACIU
CRSP
BSLN
IDIA
KURN

Competitive Long-Term Debt Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
ADC Therapeutics SA
NYSE:ADCT
Long-Term Debt
$416.3m
CAGR 3-Years
124%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
AC Immune SA
NASDAQ:ACIU
Long-Term Debt
CHf2.8m
CAGR 3-Years
16%
CAGR 5-Years
70%
CAGR 10-Years
N/A
CRISPR Therapeutics AG
NASDAQ:CRSP
Long-Term Debt
$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Basilea Pharmaceutica AG
SIX:BSLN
Long-Term Debt
CHf95.5m
CAGR 3-Years
-26%
CAGR 5-Years
-13%
CAGR 10-Years
N/A
Idorsia Ltd
SIX:IDIA
Long-Term Debt
CHf1.1B
CAGR 3-Years
25%
CAGR 5-Years
25%
CAGR 10-Years
N/A
Kuros Biosciences AG
SIX:KURN
Long-Term Debt
CHf1.6m
CAGR 3-Years
-9%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is ADC Therapeutics SA's Long-Term Debt?
Long-Term Debt
416.3m USD

Based on the financial report for Dec 31, 2023, ADC Therapeutics SA's Long-Term Debt amounts to 416.3m USD.

What is ADC Therapeutics SA's Long-Term Debt growth rate?
Long-Term Debt CAGR 3Y
124%

Over the last year, the Long-Term Debt growth was 32%. The average annual Long-Term Debt growth rates for ADC Therapeutics SA have been 124% over the past three years .